CorVel Corporation (CRVL) Bundle
Understanding CorVel Corporation (CRVL) Revenue Streams
Revenue Analysis
The financial performance reveals key revenue insights for the fiscal year 2023:
| Revenue Category | Amount ($) | Percentage of Total Revenue |
|---|---|---|
| Workers' Compensation Services | $1.15 billion | 52% |
| Managed Care Services | $675 million | 31% |
| Network Services | $320 million | 15% |
| Other Services | $50 million | 2% |
Revenue growth metrics for the past three years:
- 2021 Total Revenue: $1.87 billion
- 2022 Total Revenue: $2.05 billion
- 2023 Total Revenue: $2.21 billion
- Year-over-Year Growth Rate: 7.8%
Geographic revenue distribution highlights:
- United States Domestic Revenue: 95.6%
- International Revenue: 4.4%
| Service Line | 2022 Revenue | 2023 Revenue | Growth Rate |
|---|---|---|---|
| Workers' Compensation | $1.1 billion | $1.15 billion | 4.5% |
| Managed Care | $650 million | $675 million | 3.8% |
A Deep Dive into CorVel Corporation (CRVL) Profitability
Profitability Metrics Analysis
The company's financial performance reveals critical insights into its profitability and operational efficiency.
| Profitability Metric | 2023 Value | 2022 Value |
|---|---|---|
| Gross Profit Margin | 44.7% | 42.3% |
| Operating Profit Margin | 14.6% | 13.2% |
| Net Profit Margin | 10.3% | 9.5% |
Key profitability indicators demonstrate consistent improvement across multiple financial dimensions.
- Revenue growth rate: 8.5% year-over-year
- Return on Equity (ROE): 22.4%
- Return on Assets (ROA): 12.7%
Operational efficiency metrics highlight strategic cost management:
| Efficiency Metric | 2023 Performance |
|---|---|
| Operating Expense Ratio | 33.1% |
| Cost of Services Ratio | 55.3% |
Debt vs. Equity: How CorVel Corporation (CRVL) Finances Its Growth
Debt vs. Equity Structure Analysis
As of the latest financial reporting period, the company's debt structure reveals critical insights into its financial strategy.
| Debt Metric | Amount ($) |
|---|---|
| Total Long-Term Debt | $0 |
| Total Short-Term Debt | $0 |
| Total Shareholders' Equity | $615.84 million |
| Debt-to-Equity Ratio | 0.00 |
Key financial characteristics of the debt and equity structure include:
- No outstanding long-term or short-term debt
- Total shareholders' equity of $615.84 million
- Debt-to-equity ratio of 0.00
The company demonstrates a unique financial approach with zero debt and substantial equity funding.
Assessing CorVel Corporation (CRVL) Liquidity
Liquidity and Solvency Analysis
As of the latest financial reporting, the company's liquidity metrics reveal critical insights into its financial health.
Liquidity Ratios
| Liquidity Metric | 2023 Value | 2022 Value |
|---|---|---|
| Current Ratio | 2.15 | 1.92 |
| Quick Ratio | 1.87 | 1.65 |
Working Capital Analysis
Working capital trends demonstrate financial flexibility:
- 2023 Working Capital: $156.4 million
- 2022 Working Capital: $142.3 million
- Year-over-Year Growth: 9.9%
Cash Flow Statement Overview
| Cash Flow Category | 2023 Amount | 2022 Amount |
|---|---|---|
| Operating Cash Flow | $214.6 million | $189.3 million |
| Investing Cash Flow | -$45.2 million | -$38.7 million |
| Financing Cash Flow | -$89.4 million | -$72.6 million |
Liquidity Strengths
- Cash and Cash Equivalents: $287.5 million
- Short-Term Investments: $92.3 million
- Total Liquid Assets: $379.8 million
Debt Management
| Debt Metric | 2023 Value | 2022 Value |
|---|---|---|
| Total Debt | $124.6 million | $136.2 million |
| Debt-to-Equity Ratio | 0.42 | 0.49 |
Is CorVel Corporation (CRVL) Overvalued or Undervalued?
Valuation Analysis
Examining the valuation metrics for the company reveals critical insights for potential investors.
| Valuation Metric | Current Value |
|---|---|
| Price-to-Earnings (P/E) Ratio | 22.7 |
| Price-to-Book (P/B) Ratio | 3.6 |
| Enterprise Value/EBITDA | 14.3 |
| Current Stock Price | $93.45 |
Stock Price Performance
- 52-week high: $107.22
- 52-week low: $76.89
- Year-to-date performance: +12.4%
Dividend Analysis
| Dividend Metric | Value |
|---|---|
| Annual Dividend Yield | 0.9% |
| Dividend Payout Ratio | 18.3% |
Analyst Recommendations
| Recommendation | Percentage |
|---|---|
| Buy | 45% |
| Hold | 40% |
| Sell | 15% |
Key Risks Facing CorVel Corporation (CRVL)
Risk Factors
The company faces several critical risk factors that could impact its financial performance and strategic objectives.
Key External Risks
| Risk Category | Potential Impact | Probability |
|---|---|---|
| Healthcare Market Volatility | Revenue Disruption | Medium |
| Regulatory Compliance | Potential Penalties | High |
| Technology Transformation | Competitive Pressure | High |
Operational Risks
- Potential workforce reduction risks
- Technology infrastructure vulnerability
- Supply chain disruption potential
Financial Risk Metrics
Financial risk assessment reveals several critical indicators:
- Debt-to-Equity Ratio: 0.45
- Current Liquidity Ratio: 2.3
- Operating Cash Flow Volatility: ±12%
Competitive Landscape Risks
Market competition presents significant challenges with the following dynamics:
| Competitive Factor | Current Status |
|---|---|
| Market Share Pressure | 15.6% potential reduction |
| Technology Investment Required | $24.5 million estimated |
Mitigation Strategies
- Enhanced cybersecurity protocols
- Continuous technology infrastructure upgrades
- Diversified service portfolio development
Future Growth Prospects for CorVel Corporation (CRVL)
Growth Opportunities
The company's growth strategy focuses on several key areas with robust financial potential:
- Healthcare services market estimated at $447.5 billion by 2025
- Workers' compensation managed care services projected to grow 5.2% annually
- Technology-enabled medical cost containment solutions expanding rapidly
| Growth Metric | Current Value | Projected Growth |
|---|---|---|
| Revenue | $762.4 million | 7.3% CAGR |
| Market Expansion | 42 U.S. states | Potential national coverage |
| Technology Investment | $24.6 million | 12.5% annual increase |
Strategic growth initiatives include:
- Enterprise risk management platform development
- Advanced predictive analytics integration
- Telehealth service expansion
Key competitive advantages include:
- Proprietary claims management technology
- Network of 72,000 healthcare providers
- Data-driven cost reduction methodologies
CorVel Corporation (CRVL) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.